CONTINUE TO SITE
OR WAIT null SECS
© 2022 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
Ushering in the Golden Era of Alzheimer Drug Development?
What effect will aducanumab have on Alzheimer disease treatment?
RJ Tesi, MD, discusses the recent aducanumab FDA approval and the implications it will have on the treatment of Alzheimer disease.
Dr Tesi is CEO and Chief Medical Officer of INmuneBio.